Impact of COVID-19:
The pandemic has had ramifications for ways of working, surgical techniques, open vs minimally invasive, theatre workflow, patient and staff safety, training and education. With guidelines specific to each specialty being implemented and followed, surgeons should be able to continue to provide safe and effective care to their patients during the COVID-19 pandemic.The surgical equipment sector is heterogeneous, exhibiting wide variations in terms of demographics, consumer behavior, and price sensitivity. The decline in inflow of patients with chronic illnesses affected the revenue stream from regular in-house interventions such as non-invasive surgeries, chemotherapy, dialysis, and blood transfusion.
Despite initial setbacks due to the crisis during the second and third wave of COVID-19, the industry is expected to transform into the post-pandemic era. Implementation of a regulatory framework and clinical establishment acts to address concerns regarding inconsistency in prices of non-invasive surgeries, and quality assurance and management is expected to fuel the market’s growth. Also, improved surgical awareness among patients with chronic ailments is also expected to increase in the upcoming years.
Market influencers:
The rising incidence and prevalence of cardiovascular diseases is expected to aid the growth of suture market in India. Moreover, favourable reimbursement policies improve treatment accessibility which also aids in the market's growth. Therefore, cardiovascular disease's growing incidence and prevalence will drive the global cardiac sutures market's growth.Table of Contents
Companies Mentioned
- Centenial Surgical Suture Limited
- B. Braun Medical (India) Private Limited
- Boston Scientific (India) Private Limited
- Futura Surgicare Private Limited
- Johnson and Johnson (India) Private Limited
- Medtronic (India) Private Limited
- Orion Sutures (India) Private Limited
- Unisur Lifecare Private Limited
- DemeTECH Corporation
- Conmed Corporation
Methodology
LOADING...